Coeptis Net Debt from 2010 to 2024
| COEPW Stock | USD 0.02 0.00 0.00% |
Net Debt | First Reported 2004-09-30 | Previous Quarter 229.6 K | Current Value 637.5 K | Quarterly Volatility 1.2 M |
Check Coeptis Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Coeptis Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 719.4 K, Other Operating Expenses of 41.3 M or Total Operating Expenses of 41.3 M, as well as many indicators such as Price To Sales Ratio of 5.2 K, Dividend Yield of 0.0 or PTB Ratio of 4.43. Coeptis financial statements analysis is a perfect complement when working with Coeptis Therapeutics Valuation or Volatility modules.
Coeptis | Net Debt |
Latest Coeptis Therapeutics' Net Debt Growth Pattern
Below is the plot of the Net Debt of Coeptis Therapeutics Holdings over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Coeptis Therapeutics' Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Coeptis Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Net Debt | 10 Years Trend |
|
Net Debt |
| Timeline |
Coeptis Net Debt Regression Statistics
| Arithmetic Mean | (32,877) | |
| Coefficient Of Variation | (3,489) | |
| Mean Deviation | 752,725 | |
| Median | 152,139 | |
| Standard Deviation | 1,146,985 | |
| Sample Variance | 1.3T | |
| Range | 4M | |
| R-Value | (0.34) | |
| Mean Square Error | 1.3T | |
| R-Squared | 0.11 | |
| Significance | 0.22 | |
| Slope | (86,784) | |
| Total Sum of Squares | 18.4T |
Coeptis Net Debt History
Other Fundumenentals of Coeptis Therapeutics
Coeptis Therapeutics Net Debt component correlations
Click cells to compare fundamentals
About Coeptis Therapeutics Financial Statements
Coeptis Therapeutics investors use historical fundamental indicators, such as Coeptis Therapeutics' Net Debt, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Coeptis Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Debt | -1.9 M | -1.8 M | |
| Net Debt To EBITDA | 0.01 | 0.01 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Coeptis Stock Analysis
When running Coeptis Therapeutics' price analysis, check to measure Coeptis Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coeptis Therapeutics is operating at the current time. Most of Coeptis Therapeutics' value examination focuses on studying past and present price action to predict the probability of Coeptis Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coeptis Therapeutics' price. Additionally, you may evaluate how the addition of Coeptis Therapeutics to your portfolios can decrease your overall portfolio volatility.